List of Tables
Table 1. Global Oral Adefovir Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Oral Adefovir Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Oral Adefovir Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Oral Adefovir Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Oral Adefovir Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Oral Adefovir Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Oral Adefovir Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Oral Adefovir Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Oral Adefovir Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Oral Adefovir Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Oral Adefovir Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Oral Adefovir Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Adefovir Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Oral Adefovir Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Adefovir Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Oral Adefovir Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Oral Adefovir Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Oral Adefovir Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Oral Adefovir Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Oral Adefovir Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Oral Adefovir Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Oral Adefovir Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Oral Adefovir Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Oral Adefovir Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Oral Adefovir Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Oral Adefovir Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Oral Adefovir Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Oral Adefovir Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Oral Adefovir Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Oral Adefovir Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Oral Adefovir Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Oral Adefovir Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Oral Adefovir Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Oral Adefovir Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Oral Adefovir Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Oral Adefovir Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Oral Adefovir Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Oral Adefovir Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Oral Adefovir Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Oral Adefovir Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Oral Adefovir Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Oral Adefovir Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Oral Adefovir Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Oral Adefovir Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Oral Adefovir Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Oral Adefovir Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Oral Adefovir Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Oral Adefovir Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Oral Adefovir Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Oral Adefovir Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Oral Adefovir Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Oral Adefovir Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Oral Adefovir Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Oral Adefovir Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Oral Adefovir Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Oral Adefovir Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Oral Adefovir Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Oral Adefovir Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Oral Adefovir Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Oral Adefovir Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Oral Adefovir Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Oral Adefovir Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Oral Adefovir Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Oral Adefovir Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Oral Adefovir Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Oral Adefovir Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Oral Adefovir Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Oral Adefovir Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. GSK Company Information
Table 71. GSK Description and Business Overview
Table 72. GSK Oral Adefovir Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. GSK Oral Adefovir Drugs Product
Table 74. GSK Recent Developments/Updates
Table 75. Apotex Company Information
Table 76. Apotex Description and Business Overview
Table 77. Apotex Oral Adefovir Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Apotex Oral Adefovir Drugs Product
Table 79. Apotex Recent Developments/Updates
Table 80. Healthy Life Pharma Company Information
Table 81. Healthy Life Pharma Description and Business Overview
Table 82. Healthy Life Pharma Oral Adefovir Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Healthy Life Pharma Oral Adefovir Drugs Product
Table 84. Healthy Life Pharma Recent Developments/Updates
Table 85. Incepta Pharmaceuticals Company Information
Table 86. Incepta Pharmaceuticals Description and Business Overview
Table 87. Incepta Pharmaceuticals Oral Adefovir Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Incepta Pharmaceuticals Oral Adefovir Drugs Product
Table 89. Incepta Pharmaceuticals Recent Developments/Updates
Table 90. Wellona Pharma Company Information
Table 91. Wellona Pharma Description and Business Overview
Table 92. Wellona Pharma Oral Adefovir Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Wellona Pharma Oral Adefovir Drugs Product
Table 94. Wellona Pharma Recent Developments/Updates
Table 95. Sigmapharm Laboratories Company Information
Table 96. Sigmapharm Laboratories Description and Business Overview
Table 97. Sigmapharm Laboratories Oral Adefovir Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Sigmapharm Laboratories Oral Adefovir Drugs Product
Table 99. Sigmapharm Laboratories Recent Developments/Updates
Table 100. Chia Tai Tianqing Pharmaceutical Company Information
Table 101. Chia Tai Tianqing Pharmaceutical Description and Business Overview
Table 102. Chia Tai Tianqing Pharmaceutical Oral Adefovir Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Chia Tai Tianqing Pharmaceutical Oral Adefovir Drugs Product
Table 104. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 105. Tianjin Yaowu Academe Pharmaceutical Industry Company Information
Table 106. Tianjin Yaowu Academe Pharmaceutical Industry Description and Business Overview
Table 107. Tianjin Yaowu Academe Pharmaceutical Industry Oral Adefovir Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Tianjin Yaowu Academe Pharmaceutical Industry Oral Adefovir Drugs Product
Table 109. Tianjin Yaowu Academe Pharmaceutical Industry Recent Developments/Updates
Table 110. SL Pharma Company Information
Table 111. SL Pharma Description and Business Overview
Table 112. SL Pharma Oral Adefovir Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. SL Pharma Oral Adefovir Drugs Product
Table 114. SL Pharma Recent Developments/Updates
Table 115. Qilu Pharmaceutical Company Information
Table 116. Qilu Pharmaceutical Description and Business Overview
Table 117. Qilu Pharmaceutical Oral Adefovir Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Qilu Pharmaceutical Oral Adefovir Drugs Product
Table 119. Qilu Pharmaceutical Recent Developments/Updates
Table 120. Cosunter pharmaceutical Company Information
Table 121. Cosunter pharmaceutical Description and Business Overview
Table 122. Cosunter pharmaceutical Oral Adefovir Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Cosunter pharmaceutical Oral Adefovir Drugs Product
Table 124. Cosunter pharmaceutical Recent Developments/Updates
Table 125. Cisen Pharmaceutical Company Information
Table 126. Cisen Pharmaceutical Description and Business Overview
Table 127. Cisen Pharmaceutical Oral Adefovir Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Cisen Pharmaceutical Oral Adefovir Drugs Product
Table 129. Cisen Pharmaceutical Recent Developments/Updates
Table 130. Fangsheng Pharmaceutical Company Information
Table 131. Fangsheng Pharmaceutical Description and Business Overview
Table 132. Fangsheng Pharmaceutical Oral Adefovir Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Fangsheng Pharmaceutical Oral Adefovir Drugs Product
Table 134. Fangsheng Pharmaceutical Recent Developments/Updates
Table 135. Youcare Pharmaceutical Company Information
Table 136. Youcare Pharmaceutical Description and Business Overview
Table 137. Youcare Pharmaceutical Oral Adefovir Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Youcare Pharmaceutical Oral Adefovir Drugs Product
Table 139. Youcare Pharmaceutical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Oral Adefovir Drugs Distributors List
Table 143. Oral Adefovir Drugs Customers List
Table 144. Oral Adefovir Drugs Market Trends
Table 145. Oral Adefovir Drugs Market Drivers
Table 146. Oral Adefovir Drugs Market Challenges
Table 147. Oral Adefovir Drugs Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Oral Adefovir Drugs
Figure 2. Global Oral Adefovir Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Oral Adefovir Drugs Market Share by Type: 2025 & 2032
Figure 4. Tablets Product Picture
Figure 5. Capsules Product Picture
Figure 6. Others Product Picture
Figure 7. Global Oral Adefovir Drugs Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Oral Adefovir Drugs Market Share by Application: 2025 & 2032
Figure 9. Hospital and Clinic
Figure 10. Pharmacy
Figure 11. Other
Figure 12. Global Oral Adefovir Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Oral Adefovir Drugs Market Size (US$ Million), 2021–2032
Figure 14. Global Oral Adefovir Drugs Sales (K Units), 2021–2032
Figure 15. Global Oral Adefovir Drugs Average Price (US$/Unit), 2021–2032
Figure 16. Oral Adefovir Drugs Report Years Considered
Figure 17. Oral Adefovir Drugs Sales Share by Manufacturers in 2025
Figure 18. Global Oral Adefovir Drugs Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Oral Adefovir Drugs Players: Market Share by Revenue in Oral Adefovir Drugs in 2025
Figure 20. Oral Adefovir Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Oral Adefovir Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Oral Adefovir Drugs Sales Market Share by Country (2021–2032)
Figure 23. North America Oral Adefovir Drugs Revenue Market Share by Country (2021–2032)
Figure 24. United States Oral Adefovir Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Oral Adefovir Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Oral Adefovir Drugs Sales Market Share by Country (2021–2032)
Figure 27. Europe Oral Adefovir Drugs Revenue Market Share by Country (2021–2032)
Figure 28. Germany Oral Adefovir Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Oral Adefovir Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Oral Adefovir Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Oral Adefovir Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Oral Adefovir Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Oral Adefovir Drugs Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Oral Adefovir Drugs Revenue Market Share by Region (2021–2032)
Figure 35. China Oral Adefovir Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Oral Adefovir Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Oral Adefovir Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Oral Adefovir Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Oral Adefovir Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Oral Adefovir Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Oral Adefovir Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Oral Adefovir Drugs Sales Market Share by Country (2021–2032)
Figure 43. Latin America Oral Adefovir Drugs Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Oral Adefovir Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Oral Adefovir Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Oral Adefovir Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Oral Adefovir Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Oral Adefovir Drugs Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Oral Adefovir Drugs Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Oral Adefovir Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Oral Adefovir Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Oral Adefovir Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Oral Adefovir Drugs by Type (2021–2032)
Figure 54. Global Revenue Market Share of Oral Adefovir Drugs by Type (2021–2032)
Figure 55. Global Oral Adefovir Drugs Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Oral Adefovir Drugs by Application (2021–2032)
Figure 57. Global Revenue Market Share of Oral Adefovir Drugs by Application (2021–2032)
Figure 58. Global Oral Adefovir Drugs Price (US$/Unit) by Application (2021–2032)
Figure 59. Oral Adefovir Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
